MARKET

AMTI

AMTI

Applied Molecular Transport Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

46.13
+1.69
+3.80%
Opening 10:01 05/07 EDT
OPEN
45.11
PREV CLOSE
44.44
HIGH
46.33
LOW
45.11
VOLUME
9.06K
TURNOVER
--
52 WEEK HIGH
78.22
52 WEEK LOW
17.05
MARKET CAP
1.45B
P/E (TTM)
-23.3901
1D
5D
1M
3M
1Y
5Y
Applied Molecular Transport to Present at BofA Securities 2021 Health Care Conference
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will partici...
GlobeNewswire · 1d ago
64 Biggest Movers From Yesterday
Gainers
Benzinga · 2d ago
Biotech Applied Molecular Transport Stock Earns Relative Strength Rating Upgrade
Investor's Business Daily · 04/27 19:32
SNCA, FUBO, ITRM and AFMD among midday movers
Gainers: Celcuity (CELC) +43%.NCS Multistage (NCSM) +39%.MEDIROM Healthcare Technologies (MRM) +31%.Natuzzi (NTZ) +24%.Affimed (AFMD) +23%.Tenax Therapeutics (TENX) +23%.Brooklyn ImmunoTherapeutics (BTX) +20%.GT Biopharma (GTBP) +16%.Sohu.com (SOHU) +15%.f...
Seekingalpha · 04/09 16:39
Celcuity, GeoVax Labs leads healthcare gainers; Novo Integrated Sciences, Provention Bio among major losers
Gainers: Celcuity (CELC) +56%, GeoVax Labs (GOVX) +36%, Affimed (AFMD) +24%, Tenax Therapeutics (TENX) +22%, Genetic Technologies (GENE) +13%.Losers: Novo Integrated Sciences (NVOS) -24%, Provention Bio (PRVB) -21%, Virpax Pharmaceuticals (VRPX) -17%, Iter...
Seekingalpha · 04/09 15:00
The Independent Director of Applied Molecular Transport Inc. (NASDAQ:AMTI), David Lamond, Just Bought 2.5% More Shares
Applied Molecular Transport Inc. ( NASDAQ:AMTI ) shareholders (or potential shareholders) will be happy to see that the...
Simply Wall St. · 04/08 06:08
EBON, SLS, RMO and UCTT among midday movers
Gainers: Scienjoy (SJ) +48%.Second Sight Medical Products (EYES) +36%.Greenwich LifeSciences (GLSI) +32%.Brooklyn ImmunoTherapeutics (BTX) +31%.Romeo Power (RMO) +28%.Target Hospitality (TH) +27%.BBQ Holdings (BBQ) +27%.SELLAS Life Sciences (SLS) +22%.GT B...
Seekingalpha · 04/06 16:42
Brooklyn ImmunoTherapeutics, Greenwich LifeSciences leads healthcare gainers; Scholar Rock, Chembio Diagnostics among major losers
Gainers: Brooklyn ImmunoTherapeutics (BTX) +45%, Greenwich LifeSciences (GLSI) +16%, PAVmed (PAVM) +15%, SeaSpine Holdings (SPNE) +14%, Cara Therapeutics (CARA) +14%.Losers: Scholar Rock (SRRK) -14%, Chembio Diagnostics (CEMI) -13%, Harmony Biosciences (HR...
Seekingalpha · 04/06 15:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMTI. Analyze the recent business situations of Applied Molecular Transport Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMTI stock price target is 77.25 with a high estimate of 92.00 and a low estimate of 68.00.
EPS
Institutional Holdings
Institutions: 69
Institutional Holdings: 23.97M
% Owned: 76.33%
Shares Outstanding: 31.40M
TypeInstitutionsShares
Increased
16
2.13M
New
19
3.79M
Decreased
10
36.18K
Sold Out
3
57.74K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.30%
Pharmaceuticals & Medical Research
+1.05%
Key Executives
Non-Executive Chairman/Independent Director
Helen Kim
Chief Executive Officer/Co-Founder/Director
Tahir Mahmood
Co-Founder/Chief Scientific Officer/Director
Randall Mrsny
Chief Financial Officer
Shawn Cross
Senior Vice President - Finance
Brandon Hants
Senior Vice President
Derek Maclean
Senior Vice President
Chuck Olson
Chief Technology Officer
Douglas Rich
Vice President
Andy Whitney
Other
Elizabeth Bhatt
Other
Bittoo Kanwar
Independent Director
Graham Cooper
Independent Director
David Lamond
Independent Director
Aaron VanDevender
No Data
  • All
  • Financials
  • Insiders
More
About AMTI
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company is building a portfolio of oral product candidates based on its technology platform including its product candidate, AMT-101, an oral GI-selective rhIL-10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The Company’s other product candidate, AMT-126, is a GI-selective oral fusion of rhIL-22. The Company’s technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics, with development-stage drugs.

Webull offers kinds of Applied Molecular Transport Inc. stock information, including NASDAQ:AMTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMTI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMTI stock methods without spending real money on the virtual paper trading platform.